An increase in CD62Ldim neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.
Roy SpijkermanNikita K N JorritsmaSuzanne H BongersBas J J BindelsBernard N JukemaLillian HesselinkFalco HietbrinkLuke P H LeenenHarriët M R van GoorNienke VrisekoopKarin A H KaasjagerLeo Koendermannull nullPublished in: Scandinavian journal of immunology (2021)
The increase in this neutrophil phenotype indicates that the increased number of CD16bright /CD62Ldim neutrophils might be used as prognostic marker to predict those patients that will develop PE in critical COVID-19 patients.